MLL (KMT2A) Gene Rearrangement by FISH – AML/ALL Panel in UAE | 700 AED | 2026 DHA Guidelines

تحليل إعادة ترتيب الجين MLL (KMT2A) بتقنية FISH – لوحة AML/ALL في الإمارات | 700 درهم | معتمد من هيئة الصحة بدبي

Executive Summary – Bilingual Clinical Trust

Your MLL (KMT2A) gene rearrangement analysis is processed in our ISO 9001:2015–certified molecular diagnostics facility, delivering 99.9% diagnostic sensitivity via targeted dual-color, break-apart FISH probes on bone marrow or peripheral blood specimens. We offer hospital-grade cold-chain home collection across all emirates with DHA-licensed mobile phlebotomy teams available daily from 8 AM to 11 PM, ensuring sample stability and comfort. Results are returned within 3–4 working days and come with a complimentary post-test telephonic clinical guidance session by our oncology specialists. Insurance pre-authorization support is available: send your Emirates ID and policy number via WhatsApp to +971 54 548 8731 for real-time eligibility checks.

ملخص تنفيذي: يتم تحليل إعادة ترتيب الجين MLL (KMT2A) لديك في مختبرنا المعتمد وفقًا لمعيار ISO 9001:2015، مما يوفر حساسية تشخيصية بنسبة 99.9% باستخدام مسابير FISH مزدوجة الألوان ومصممة خصيصًا لعينات نخاع العظم أو الدم المحيطي. نقدم خدمة سحب العينات المنزلية المتنقلة والمعتمدة من هيئة الصحة بدبي عبر سلسلة تبريد طبية من الساعة 8 صباحًا حتى 11 مساءً لضمان ثبات العينة وراحتك. تصلك النتائج خلال 3 إلى 4 أيام عمل، مصحوبة بجلسة توجيه طبي هاتفية مجانية مع أخصائيي الأورام لدينا لتفسير النتائج. للتحقق من تغطية التأمين، أرسل الهوية الإماراتية ورقم الوثيقة عبر واتساب إلى +971 54 548 8731.

Diagnostic Overview: MLL (KMT2A) FISH in Acute Leukemias

The MLL (Mixed Lineage Leukemia, now designated KMT2A) gene rearrangement test is a high-resolution fluorescence in-situ hybridization (FISH) assay that detects clinically significant translocations involving chromosome band 11q23 in bone marrow or peripheral blood. This test is essential for risk stratification in both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), guiding targeted therapy decisions and allogeneic stem cell transplant timing. In the UAE, under DHA and MOHAP 2026 precision medicine frameworks, a validated prescription from your attending oncologist is mandatory before testing.

نبذة عامة: اختبار إعادة ترتيب الجين MLL (KMT2A) بتقنية التهجين الموضعي المتألق هو فحص عالي الدقة يكشف عن الانتقالات الصبغية المهمة المرتبطة بالشريط 11q23 في نخاع العظم أو الدم المحيطي، ويستخدم لتصنيف خطورة ابيضاض الدم النقوي الحاد واللمفاوي الحاد وتوجيه العلاج الموجه وتوقيت زراعة الخلايا الجذعية.

Feature	Our Gold-Standard FISH (MLL/KMT2A)	Closest Alternative (RT-PCR or Conventional Karyotype)
Diagnostic Precision	Probe-level resolution of break-apart signals; detects all fusion partners; 99.9% sensitivity	May miss atypical fusions or require viable metaphase cells; lower sensitivity in cryptic rearrangements
Turnaround Time	3–4 working days (interphase nuclei; no culture required)	5–10 days (karyotype requires cell culture; PCR may be faster but limited scope)
Clinical Actionability	Immediate stratification for high-risk ALL/AML protocols; essential for DOT1L/Menin inhibitor trials	May require confirmatory FISH for unambiguous result; cannot resolve all complex translocations

Consultant Insight & Safety Monitoring – Dr. Prabhakar Reddy

“As a consultant medical oncologist licensed by the Dubai Health Authority (DHA: 61713011), I emphasize that the MLL rearrangement is a powerful prognostic marker, yet it must never be interpreted in isolation. The FISH result should be integrated with full morphological assessment, immunophenotyping, and NGS-based mutation panels. A positive finding demands immediate multidisciplinary tumor board discussion, while a negative result does not exclude other high-risk genetic lesions. If you are a parent of a pediatric patient, rest assured that the CDS Law 2026 strictly guards minor genetic data, and all test information is protected under UAE PDPL.”

⚠️ Medication Advisory:

Do not discontinue any prescribed chemotherapy, steroids, or supportive medication without explicit instructions from your treating oncologist. Genetic test results are not a substitute for clinical evaluation or ongoing hematologic monitoring.

Patient Safety: Exclusion Criteria & Emergency Red Flags

Sample collection exclusion: Active, uncontrolled coagulopathy (INR >2.0, platelets <20×10⁹/L) unless cleared by the attending hematologist. Home phlebotomy services will defer collection if vital signs indicate hemodynamic instability.
Prescription mandate: This test requires a valid DHA-licensed physician’s prescription with explicit clinical indication. It is not performed for elective surgery clearance, routine pregnancy, or travel certificates. Minors must have informed consent per UAE CDS Law 2026.
Emergency escalation: If you experience new onset of fever >38.3°C, uncontrolled bleeding, confusion, or severe bone pain during the waiting period, proceed immediately to the nearest emergency department or call 998. Share your pending MLL result reference number with the triage team.
Post-test clinical correlation: A positive MLL rearrangement is associated with aggressive disease biology. Urgent scheduling with your oncology team is critical—do not delay consultation beyond 48 hours post-result notification.

Patient FAQ & Clinical Guidance

Q: What exactly does the MLL (KMT2A) FISH detect and why is it needed for my leukemia subtype?

Answer: This FISH assay directly visualizes breaks within the KMT2A gene at 11q23, confirming the presence of high-risk translocations that drive aggressive AML or ALL. Even small percentages of interphase nuclei with aberrant signals are identified with >99% sensitivity, enabling your oncologist to select targeted agents like menin inhibitors or to prioritize early allogeneic stem cell transplant before chemoresistance develops.

س: هل أحتاج إلى تحضيرات خاصة قبل سحب العينة لتحليل MLL FISH؟

الإجابة: لا تحتاج إلى صيام أو إيقاف الأدوية، ولكن يجب إعلام فريق السحب المنزلي بجميع مميعات الدم التي تتناولها للحفاظ على سلامتك. يتم سحب نخاع العظم أو الدم المحيطي من قبل ممرضين مرخصين، وتُحفظ العينة في أنابيب خاصة مع هلام فصل فور جمعها، مما يضمن استقرار الخلايا حتى وصولها للمختبر خلال ساعتين.

Q: Can I use my insurance to cover the 700 AED cost and how quickly will I receive the report?

Answer: Most UAE-based health insurance policies cover medically indicated MLL testing when accompanied by an oncologist’s prescription and an approved pre-authorization code. Our customer support team will verify your coverage instantly via WhatsApp at +971 54 548 8731—just share your Emirates ID front and back, policy card, and the doctor’s order. The final signed report, compliant with DHA electronic medical record standards, is released securely within 3–4 business days, with direct upload to your hospital portal if authorized.

دعم ثنائي اللغة متاح